<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD006205-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD006205-sec-0008"></div> <div class="table" id="CD006205-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Elective neck dissection versus therapeutic (delayed) neck dissection</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Elective neck dissection versus therapeutic (delayed) neck dissection</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> elective ND </p> <p><b>Comparison:</b> therapeutic (delayed) ND </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (therapeutic ND)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (elective ND)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>350<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>241 per 1000</p> <p>(194 to 301)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>HR 0.64</b> </p> <p>(0.50 to 0.83)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>883</p> <p>(4 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>c</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>We calculated mortality in place of overall survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>250<sup>b</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>168 per 1000 (134 to 212)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>550<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>361 per 1000</p> <p>(302 to 428)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>HR 0.56</b> </p> <p>(0.45 to 0.70)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>954</p> <p>(5 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>c</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>We calculated new disease, progression, and mortality in place of disease‐free survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>450<sup>b</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>285 per 1000</p> <p>(236 to 342)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>300<sup>b</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>187 per 1000</p> <p>(142 to 243)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 0.58</b> </p> <p>(0.43 to 0.78)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>458</p> <p>(4 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>c</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>600<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>348 per 1000</p> <p>(288 to 420)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.58</b> (0.48 to 0.70) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>633</p> <p>(3 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>c</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.31</b> </p> <p>(1.11 to 1.54)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>746</p> <p>(2 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>d</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk not calculated as event rate (in the therapeutic groups) in 1 study was 3.6% compared with 60.5% in the other study. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>ND:</b> neck dissection; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Based on data from <a href="./references#CD006205-bbs2-0003">D'Cruz 2015</a> (lower‐middle income country).<br><sup>b</sup> Based on data from <a href="./references#CD006205-bbs2-0007">Hutchison 2019</a> (high‐income country).<br><sup>c</sup> Downgraded once due to risk of bias.<br><sup>d</sup> Downgraded once for risk of bias as only 2/5 trials provided data on adverse events (selective reporting of subjective outcomes). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">Elective radical neck dissection versus elective selective neck dissection</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Elective radical neck dissection versus elective selective neck dissection</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> elective radical ND </p> <p><b>Comparison:</b> elective selective ND </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (elective selective ND)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (elective radical ND)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>252<br>(2 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2 trials reported HR for mortality but used different surgical procedures, so we could not pool data. Neither trial indicated any difference in mortality between the 2 interventions. </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> <p>Follow‐up: 5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>300<sup>b</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>184 per 1000<br>(142 to 243) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 0.57</b> </p> <p>(0.29 to 1.11)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>104<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>c</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>These data were calculated from the reported HR for disease‐free survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> <p>Follow‐up: 5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>250<sup>d</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>303 per 1000<br>(158 to 583) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.21</b> </p> <p>(0.63 to 2.33)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>143<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>e</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>1 trial reported the following adverse events: flap necrosis, wound infection, fistula, vascular rupture, haematoma, seroma, and chyle fistula. There were no complications in 45 participants (59%) in the modified radical neck dissection group and no complications in 54 participants (75%) in the elective neck dissection group. There were 2 postoperative deaths in the modified radical neck dissection group and 1 postoperative death in the elective neck dissection group. </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>148</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>Low</b><sup>f</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>ND:</b> neck dissection; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded twice for very serious inconsistency and once for unclear/high risk of bias.<br><sup>b</sup> Based on data from <a href="./references#CD006205-bbs2-0003">D'Cruz 2015</a> and <a href="./references#CD006205-bbs2-0007">Hutchison 2019</a>.<br><sup>c</sup> Downgraded twice for very serious imprecision and once for high risk of bias.<br><sup>d</sup> Based on data from <a href="./references#CD006205-bbs2-0001">BHNCSG 1998</a>.<br><sup>e</sup> Downgraded twice for very serious imprecision and once for unclear risk of bias.<br><sup>f</sup> Downgraded twice for very serious risk of bias. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">Superselective neck dissection versus selective neck dissection</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral or oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> superselective ND </p> <p><b>Comparison:</b> selective ND </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (selective ND)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (superselective ND)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>One study reported no clear difference between the interventions, but we were unable to use the data. </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>72</p> <p>(2 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data not presented in a useable way and inconsistent. 1 study reported no evidence of a difference. The other study reported lower recurrence in the superselective ND group. </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported in a usable way in either study.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>No adverse events reported.</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>72</p> <p>(2 RCTs)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>ND:</b> neck dissection; <b>RCT:</b> randomised controlled trial. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded twice for very serious imprecision and once for unclear risk of bias. We were unable to use the data presented.<br><sup>b</sup> Downgraded twice for very serious imprecision and once for high risk of bias for subjective outcomes. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span> <span class="table-title">Supraomohyoid neck dissection versus modified radical neck dissection</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Supraomohyoid neck dissection versus modified radical neck dissection</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral or oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> supraomohyoid ND </p> <p><b>Comparison:</b> modified radical ND </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (modified radical ND)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (supraomohyoid ND)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>Significant difference in complication rates, with lower rates for the supraomohyoid procedure. </p> <p>UW‐QOL scores for all disease‐free survivors were assessed at 1 year after treatment. Scores from 9 disease‐specific domains appeared to show that supraomohyoid ND was superior to modified radical ND in the domains of pain relief (78.8% vs 75.2%, P = 0.013) and shoulder function (81.1% vs 68.1%, P &lt; 0.001), but not in any other domain. </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>332</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>ND:</b> neck dissection; <b>RCT:</b> randomised controlled trial; <b>UW‐QOL:</b> University of Washington Quality of Life Questionnaire. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded twice for very serious imprecision and once for high risk of bias for subjective outcomes. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span> <span class="table-title">Sentinel node biopsy versus elective neck dissection</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Sentinel node biopsy versus elective neck dissection</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral or oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> sentinel node biopsy </p> <p><b>Comparison:</b> elective ND </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (elective ND)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (sentinel node biopsy)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> <p>(182 to 219)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 1.00</b> </p> <p>(0.90 to 1.11)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>279</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>Low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We calculated total mortality in place of overall survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>300<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>295 per 1000</p> <p>(275 to 317)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 0.98</b> </p> <p>(0.90 to 1.07)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>279</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>Low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We calculated new disease, progression, and mortality in place of disease‐free survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200<sup>c</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>207 per 1000</p> <p>(184 to 233)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 1.04</b> </p> <p>(0.91 to 1.19)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>279</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>Low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>279</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>d</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"[...] the number of patients with recurrences in both arms was almost identical."</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="4" rowspan="1" class="table-tint table-highlight"> <p>No adverse events were reported.</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very</b><b>low</b><sup>d</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>ND:</b> neck dissection; <b>RCT:</b> randomised controlled trial. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Based on data from <a href="./references#CD006205-bbs2-0003">D'Cruz 2015</a> and <a href="./references#CD006205-bbs2-0007">Hutchison 2019</a> for elective neck dissection.<br><sup>b</sup> Downgraded once for imprecision and once for unclear risk of bias.<br><sup>c</sup> Based on data from <a href="./references#CD006205-bbs2-0007">Hutchison 2019</a> for elective neck dissection.<br><sup>d</sup> Downgraded twice for very serious imprecision and once for high risk of bias for subjective outcomes. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0006"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 6.</span> <span class="table-title">PET‐CT following chemoradiotherapy versus planned neck dissection before or after chemoradiotherapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>PET‐CT following chemoradiotherapy versus planned neck dissection before or after chemoradiotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral or oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> PET‐CT following chemoradiotherapy </p> <p><b>Comparison:</b> planned ND before or after chemoradiotherapy </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>No of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (planned ND)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (PET‐CT)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>186 per 1000<br>(135 to 253) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 0.92</b> </p> <p>(0.65 to 1.31)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>564<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>These data were calculated from the reported HR for overall survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported in a usable way.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200<sup>c</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000 (189 to 211)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 1.00</b> (0.94 to 1.06) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>564<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>Moderate</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome not reported in a usable way.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="4" rowspan="1" class="table-tint table-highlight"> <p>22 surgical complications in PET‐CT group compared with 83 in planned surgery group.</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>d</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>ND:</b> neck dissection; <b>PET‐CT:</b> positron emission tomography–computed tomography; <b>RCT:</b> randomised controlled trial. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Based on data from <a href="./references#CD006205-bbs2-0003">D'Cruz 2015</a> and <a href="./references#CD006205-bbs2-0007">Hutchison 2019</a> for elective ND.<br><sup>b</sup> Downgraded once due to imprecision.<br><sup>c</sup> Based on data from <a href="./references#CD006205-bbs2-0007">Hutchison 2019</a> for elective ND.<br><sup>d</sup> Downgraded twice for very serious imprecision and once for high risk of bias for subjective outcomes. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0007"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 7.</span> <span class="table-title">Surgery plus radiotherapy versus radiotherapy alone</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Surgery plus radiotherapy versus radiotherapy alone</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral or oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> surgery + radiotherapy </p> <p><b>Comparison:</b> radiotherapy alone </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (radiotherapy alone)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (surgery + radiotherapy)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>153 per 1000<br>(67 to 336) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 0.24</b> </p> <p>(0.10 to 0.59)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>These data were calculated from the reported HR for overall survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>Both groups reported the following severe acute adverse effects: subcutaneous fibrosis; telangiectasia (1–4 cm²); and moderate‐to‐severe oedema, xerostomia, trismus, and dysphagia. Subcutaneous fibrosis was more prevalent in the surgery + radiotherapy group (P = 0.042), but the prevalence of other adverse effects appeared to be similar in both groups. </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low<sup>c</sup></b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR</b>: hazard ratio; <b>RCT:</b> randomised controlled trial. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Based on data presented by <a href="./references#CD006205-bbs2-0118">Warnakulasuriya 2009</a><sup>.</sup><br><sup>b</sup> Downgraded twice for very serious imprecision and once for high risk of bias.<br><sup>c</sup> Downgraded twice for very serious imprecision and once for high risk of bias for subjective outcomes. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0008"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 8.</span> <span class="table-title">Surgery versus radiotherapy alone</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Surgery versus radiotherapy alone</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> surgery </p> <p><b>Comparison:</b> radiotherapy alone </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (radiotherapy alone)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (surgery)</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500<sup>a</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>437 per 1000<br>(60 to 994) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 0.83</b> </p> <p>(0.09 to 7.46)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>68</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>Low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We calculated mortality in place of overall survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>600<sup>c</sup> per 1000 </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>625 per 1000<br>(219 to 979) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HR 1.07</b> </p> <p>(0.27 to 4.22)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>68</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>Low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We calculated new disease, progression, and mortality in place of disease‐free survival.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported.</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>Both groups reported the following severe acute adverse effects: subcutaneous fibrosis, telangiectasia (1–4 cm²), and moderate‐to‐severe oedema, xerostomia, trismus, and dysphagia. Subcutaneous fibrosis was more prevalent in the surgery + radiotherapy group (P = 0.042), but the prevalence of other adverse effects appeared to be similar in both groups. </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>68</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>d</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR</b>: hazard ratio; <b>RCT:</b> randomised controlled trial. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Based on data presented by <a href="./references#CD006205-bbs2-0118">Warnakulasuriya 2009</a>.<br><sup>b</sup> Downgraded twice for very serious imprecision.<br><sup>c</sup> For illustrative purposes only.<br><sup>d</sup> Downgraded twice for very serious imprecision and once for high risk of bias for subjective outcomes. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006205-tbl-0009"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 9.</span> <span class="table-title">Surgery plus adjuvant radiotherapy versus chemotherapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Surgery plus adjuvant radiotherapy versus chemotherapy</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> adults with oral or oropharyngeal cancer </p> <p><b>Setting:</b> inpatient </p> <p><b>Intervention:</b> surgery + adjuvant radiotherapy </p> <p><b>Comparison:</b> chemotherapy </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk (chemotherapy)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk (surgery + adjuvant radiotherapy)</b> </p> </th> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Total mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study reported that survival was significantly better in participants who underwent surgery and RT compared with the CRT group, but there were no useable data. </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>New disease, progression, and mortality</b> </p> <p>Follow‐up: 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>—</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Locoregional recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>Very low</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported difference between groups not "statistically significant" (P = 0.355), but there were no useable data. </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported for the oral cancer subgroup.</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events associated with treatment</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>—</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not reported for any participants.</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>RCT:</b> randomised controlled trial. </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
</tbody>
<tfoot><tr>
<td colspan="8"> <div class="table-footnote"> <p><sup>a</sup> Estimated from chemotherapy arm of <a href="./references#CD006205-bbs2-0008">Iyer 2015</a>.<br><sup>b</sup> Downgraded twice for very serious imprecision and once for high risk of bias. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
